There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Verastem (VSTM – Research Report), ANI Pharmaceuticals (ANIP – Research Report) and Argenx Se (ARGX – Research Report) with bullish sentiments.
Verastem (VSTM)
In a report released today, Srikripa Devarakonda from Truist Financial reiterated a Buy rating on Verastem, with a price target of $34.00. The company’s shares closed last Friday at $11.85.
According to TipRanks.com, Devarakonda is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Verastem with a $29.30 average price target, implying a 149.4% upside from current levels. In a report issued on May 9, BTIG also maintained a Buy rating on the stock with a $27.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
ANI Pharmaceuticals (ANIP)
Truist Financial analyst Les Sulewski maintained a Buy rating on ANI Pharmaceuticals today. The company’s shares closed last Friday at $68.05, close to its 52-week high of $70.81.
According to TipRanks.com, Sulewski is a 4-star analyst with an average return of
Currently, the analyst consensus on ANI Pharmaceuticals is a Strong Buy with an average price target of $81.33, which is a 16.2% upside from current levels. In a report released today, H.C. Wainwright also reiterated a Buy rating on the stock with a $87.00 price target.
Argenx Se (ARGX)
Truist Financial analyst Joon Lee maintained a Buy rating on Argenx Se today. The company’s shares closed last Friday at $374.63.
According to TipRanks.com, Lee is a 5-star analyst with an average return of
Currently, the analyst consensus on Argenx Se is a Moderate Buy with an average price target of $475.79, which is a 24.3% upside from current levels. In a report issued on May 9, Wells Fargo also maintained a Buy rating on the stock with a $478.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on VSTM:
